Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biphasic Remogliflozin Etabonate in Type 2 Diabetes
NCT02537470Phase 2Completed
- Sponsor
- BHV Pharma
- Start
- Jul 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of remogliflozin etabonate in type 2 diabetes mellitus (T2DM), sponsored by BHV Pharma. Started Jul 2015; status: completed.
02
Drugs
remogliflozin etabonate
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02537470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02537470.